Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Antidiabetic Drugs
100%
Cardiometabolic Effects
100%
Metabolic Syndrome
25%
Cardiovascular Risk
16%
Diabetes
8%
Type 2 Diabetic Patients
8%
Ischemic Heart Disease
8%
Heart Disease
8%
Cardiac Dysfunction
8%
Narrative Review
8%
Leading Causes of Death
8%
PubMed
8%
Clinical Outcomes
8%
Obesity
8%
Heart Failure
8%
Small Clinical Trials
8%
Clear Effect
8%
Liver
8%
Medical Treatment
8%
Cardiovascular Function
8%
Randomized Controlled Trial
8%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Antidiabetic Agent
100%
Metabolic Syndrome
25%
Cardiovascular Physiology
8%
Cardiovascular Disease
8%
Randomized Controlled Trial
8%
Atherosclerosis
8%
Congestive Heart Failure
8%
Patient with Type 2 Diabetes
8%
Diabetes
8%
Heart Disease
8%
Cardiovascular Risk
8%
Ischemic Heart Disease
8%
Combination Therapy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
100%
Nonalcoholic Fatty Liver
100%
Metabolic Syndrome X
25%
Atherosclerosis
8%
Randomized Controlled Trial
8%
Heart Disease
8%
Cardiovascular Risk
8%
Cardiovascular Disease
8%
Combination Therapy
8%
Ischemic Heart Disease
8%
Non Insulin Dependent Diabetes Mellitus
8%
Congestive Heart Failure
8%